Home / Sweden / Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) No short position is open on this share today.
Follow
0.00% of the capital sold short
0 disclosing funds
243 disclosures on record
Evolution of the disclosed total 0% 1%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. Over the whole history, the total peaked at 2.90% on October 31, 2016. The shaded band matches the twelve months of the first chart. April 23, 2014 today
Open positions No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Follow by RSS
Get the moves on Swedish Orphan Biovitrum AB (publ) by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures 243 disclosures on record for this share. Date Fund % of capital End of publication June 19, 2016 Millennium International Management LP 0.80% June 8, 2016 Millennium International Management LP 0.70% June 7, 2016 Millennium International Management LP 0.70% May 18, 2016 Millennium International Management LP 0.61% May 17, 2016 Millennium International Management LP 0.61% May 16, 2016 Millennium International Management LP 0.56% May 15, 2016 Millennium International Management LP 0.56% May 13, 2016 Millennium International Management LP 0.60% May 12, 2016 Millennium International Management LP 0.60% May 4, 2016 Millennium International Management LP 0.59% May 3, 2016 Millennium International Management LP 0.59% April 28, 2016 Marshall Wace LLP 0.52% April 27, 2016 Millennium International Management LP 0.69% April 27, 2016 Marshall Wace LLP 0.52% April 26, 2016 Millennium International Management LP 0.69% April 20, 2016 Millennium International Management LP 0.72% April 19, 2016 Millennium International Management LP 0.72% April 4, 2016 Marshall Wace LLP 0.53% April 3, 2016 Marshall Wace LLP 0.53% March 10, 2016 Marshall Wace LLP 0.60% March 9, 2016 Millennium International Management LP 0.65% March 9, 2016 Marshall Wace LLP 0.60% March 8, 2016 Millennium International Management LP 0.65% March 7, 2016 Millennium International Management LP 0.75% March 6, 2016 Millennium International Management LP 0.75% March 4, 2016 Marshall Wace LLP 0.50% March 3, 2016 Millennium International Management LP 0.88% March 3, 2016 Marshall Wace LLP 0.50% March 2, 2016 Millennium International Management LP 0.88% March 1, 2016 Millennium International Management LP 0.90% March 1, 2016 Bridger Management LLC 0.55% February 29, 2016 Millennium International Management LP 0.84% February 29, 2016 Bridger Management LLC 0.55% February 28, 2016 Millennium International Management LP 0.84% February 26, 2016 Millennium International Management LP 0.79% February 25, 2016 Millennium International Management LP 0.80% February 24, 2016 Millennium International Management LP 0.77% February 23, 2016 Millennium International Management LP 0.69% February 22, 2016 Millennium International Management LP 0.70% February 21, 2016 Millennium International Management LP 0.70% February 9, 2016 Citadel Advisors LLC 0.53% February 8, 2016 Citadel Advisors LLC 0.53% February 5, 2016 Millennium International Management LP 0.61% February 4, 2016 Citadel Advisors LLC 0.67% February 4, 2016 Millennium International Management LP 0.61% February 3, 2016 Citadel Advisors LLC 0.67% January 13, 2016 Millennium International Management LP 0.51% January 12, 2016 Millennium International Management LP 0.51% December 21, 2015 Citadel Advisors LLC 0.77% December 20, 2015 Citadel Advisors LLC 0.77%
Download 243 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 4 of 5
Other companies sold short in Sweden Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Swedish Orphan Biovitrum AB (publ), source Finansinspektionen, data as at June 18, 2025, https://www.quivad.com/action/swedish-orphan-biovitrum-ab-publ?page=4